BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 23295157)

  • 1. Anti-human VWF monoclonal antibody SZ-123 prevents arterial thrombus formation by inhibiting VWF-collagen and VWF-platelet interactions in Rhesus monkeys.
    Zhao YM; Jiang M; Ji SD; He Y; Shen F; Li XM; Ruan CG
    Biochem Pharmacol; 2013 Apr; 85(7):945-53. PubMed ID: 23295157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chimeric monoclonal antibody MHCSZ-123 against human von Willebrand factor A3 domain inhibits high-shear arterial thrombosis in a Rhesus monkey model.
    Ji S; Jiang M; Yan B; Shen F; He Y; Wan A; Xia L; Ruan C; Zhao Y
    J Hematol Oncol; 2017 May; 10(1):111. PubMed ID: 28526067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of the von Willebrand (VWF)-collagen interaction by an antihuman VWF monoclonal antibody results in abolition of in vivo arterial platelet thrombus formation in baboons.
    Wu D; Vanhoorelbeke K; Cauwenberghs N; Meiring M; Depraetere H; Kotze HF; Deckmyn H
    Blood; 2002 May; 99(10):3623-8. PubMed ID: 11986216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-thrombotic effects and bleeding risk of AJvW-2, a monoclonal antibody against human von Willebrand factor.
    Kageyama S; Yamamoto H; Nagano M; Arisaka H; Kayahara T; Yoshimoto R
    Br J Pharmacol; 1997 Sep; 122(1):165-71. PubMed ID: 9298543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-human vWF monoclonal antibody, AJvW-2 Fab, inhibits repetitive coronary artery thrombosis without bleeding time prolongation in dogs.
    Kageyama S; Yamamoto H; Nakazawa H; Yoshimoto R
    Thromb Res; 2001 Mar; 101(5):395-404. PubMed ID: 11297756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The von Willebrand factor antagonist (GPG-290) prevents coronary thrombosis without prolongation of bleeding time.
    Wadanoli M; Sako D; Shaw GD; Schaub RG; Wang Q; Tchernychev B; Xu J; Porter TJ; Huang Q
    Thromb Haemost; 2007 Aug; 98(2):397-405. PubMed ID: 17721623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet-vessel wall interactions in thrombosis and restenosis role of von Willebrand factor.
    Hoylaerts MF
    Verh K Acad Geneeskd Belg; 1997; 59(3):161-83. PubMed ID: 9490916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of antibodies that interfere with the collagen-VWF-GPIb axis as new antithrombotics.
    Deckmyn H; Cauwenberghs N; Wu D; Depraetere H; Vanhoorelbeke K
    Verh K Acad Geneeskd Belg; 2005; 67(1):55-65. PubMed ID: 15828307
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The humanized anti-glycoprotein Ib monoclonal antibody h6B4-Fab is a potent and safe antithrombotic in a high shear arterial thrombosis model in baboons.
    Fontayne A; Meiring M; Lamprecht S; Roodt J; Demarsin E; Barbeaux P; Deckmyn H
    Thromb Haemost; 2008 Oct; 100(4):670-7. PubMed ID: 18841291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antithrombotic effect of aurin tricarboxylic acid in the guinea pig is not solely due to its interaction with the von Willebrand factor-GPIb axis.
    Azzam K; Cissé-Thiam M; Drouet L
    Thromb Haemost; 1996 Jan; 75(1):203-10. PubMed ID: 8713802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibition of thrombus formation by anti-Willebrand monoclonal antibodies in the guinea pig].
    Cissé-Thiam M; Girma JP; Meyer D; Drouet L
    Dakar Med; 1999; 44(1):45-8. PubMed ID: 10797986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Characterization and functional studies of vWF A3 domain monoclonal antibodies that inhibit binding of vWF to collagen].
    Zhao YM; Dong NZ; Shen F; Xie LQ; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2008 Mar; 29(3):171-4. PubMed ID: 18788616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.
    Uemura T; Kawasaki T; Taniguchi M; Moritani Y; Hayashi K; Saito T; Takasaki J; Uchida W; Miyata K
    Br J Pharmacol; 2006 May; 148(1):61-9. PubMed ID: 16520742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative antithrombotic effects of monoclonal antibodies targeting different platelet glycoprotein-adhesive molecule interactions in nonhuman primates.
    Cadroy Y; Hanson SR; Kelly AB; Marzec UM; Evatt BL; Kunicki TJ; Montgomery RR; Harker LA
    Blood; 1994 Jun; 83(11):3218-24. PubMed ID: 8193356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity.
    Barstad RM; Stephens RW; Hamers MJ; Sakariassen KS
    Thromb Haemost; 2000 Feb; 83(2):334-7. PubMed ID: 10739395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aurin tricarboxylic acid inhibits platelet adhesion to collagen by binding to the 509-695 disulphide loop of von Willebrand factor and competing with glycoprotein Ib.
    Girma JP; Fressinaud E; Christophe O; Rouault C; Obert B; Takahashi Y; Meyer D
    Thromb Haemost; 1992 Dec; 68(6):707-13. PubMed ID: 1287886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The in vitro effect of the new antithrombotic drug candidate ALX-0081 on blood samples of patients undergoing percutaneous coronary intervention.
    van Loon JE; de Jaegere PP; Ulrichts H; van Vliet HH; de Maat MP; de Groot PG; Simoons ML; Leebeek FW
    Thromb Haemost; 2011 Jul; 106(1):165-71. PubMed ID: 21655675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are integrin alpha(2)beta(1), glycoprotein Ib and vWf levels correlated with their contributions to platelet adhesion on collagen under high-shear flow?
    Jung SM; Sonoda M; Tsuji K; Jimi A; Nomura S; Kanaji T; Moroi M
    Platelets; 2010; 21(2):101-11. PubMed ID: 20063990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihemostatic and antithrombotic effects of monoclonal antibodies against von Willebrand factor in nonhuman primates.
    Krupski WC; Bass A; Cadroy Y; Kelly AB; Harker LA; Hanson SR
    Surgery; 1992 Aug; 112(2):433-9; discussion 439-40. PubMed ID: 1641780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a myeloma patient with a life-threatening hemorrhagic diathesis: presence of a lambda dimer protein inhibiting shear-induced platelet aggregation by binding to the A1 domain of von Willebrand factor.
    Shinagawa A; Kojima H; Berndt MC; Kaneko S; Suzukawa K; Hasegawa Y; Shigeta O; Nagasawa T
    Thromb Haemost; 2005 May; 93(5):889-96. PubMed ID: 15886805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.